Furthermore, while TET2 mutations are more frequent in chronic myelomonocytic leukemia (CMML) than in AML, IDH1/2 mutations are more common in AML than in CMML [32,33]. The gene discussed is IDH1; the disease is chronic myelomonocytic leukemia.